Skip to main content
. Author manuscript; available in PMC: 2019 Oct 4.
Published in final edited form as: Eur Respir J. 2018 Oct 4;52(4):1801350. doi: 10.1183/13993003.01350-2018

FIGURE 1.

FIGURE 1

Treatment cascade. a) 12% of estimated multidrug-resistant (MDR) or rifampicin-resistant (RR) tuberculosis (TB) cases and b) 6.8% of estimated extensively drug-resistant (XDR)-TB cases are diagnosed, initiated on appropriate treatment and cured of their drug-resistant TB disease. Data from [1].